A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours

Clinical trial NCT04882176 · TERMINATED

Trial details

NCT number: NCT04882176
Sponsor: LaNova Medicines Limited
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Tumours

Start date: 2021-05-20
Primary completion: 2023-02-07
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.